Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HRS-4642 Combined With AG as Conversion Therapy for Locally Advanced Pancreatic Cancer
NCT07438106Phase 2Recruiting
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Jan 2026
- Primary completion
- Oct 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HRS-4642 in pancreatic cancer (PC), sponsored by Jiangsu Provincial People's Hospital. Started Jan 2026; status: recruiting.
02
Drugs
HRS-4642
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT07438106.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07438106.